Literature DB >> 23462507

Cross-desensitization and cointernalization of H1 and H2 histamine receptors reveal new insights into histamine signal integration.

Natalia Alonso1, Natalia Fernandez, Cintia Notcovich, Federico Monczor, May Simaan, Alberto Baldi, J Silvio Gutkind, Carlos Davio, Carina Shayo.   

Abstract

G protein-coupled receptor signaling does not result from sequential activation of a linear pathway of proteins/enzymes, but rather from complex interactions of multiple, branched signaling routes, i.e., signaling networks. In this work we present an exhaustive study of the cross-talk between H1 and H2 histamine receptors (H1R and H2R) in U937 cells and Chinese hamster ovary-transfected cells. By desensitization assays we demonstrated the existence of a crossdesensitization between both receptors independent of protein kinase A or C. H1R-agonist stimulation inhibited cell proliferation and induced apoptosis in U937 cells following treatment of 48 hours. H1R-induced antiproliferative and apoptotic response was inhibited by an H2R agonist suggesting that the cross-talk between both receptors modifies their function. Binding and confocal microscopy studies revealed cointernalization of both receptors upon treatment with the agonists. To evaluate potential heterodimerization of the receptors, sensitized emission fluorescence resonance energy transfer experiments were performed in human embryonic kidney 293T cells using H1R-cyan fluorescent protein and H2R-yellow fluorescent protein. To our knowledge these findings may represent the first demonstration of agonist-induced heterodimerization of the H1R and H2R. In addition, we also show that the inhibition of the internalization process did not prevent receptor crossdesensitization, which was mediated by G protein-coupled receptor kinase 2. Our study provides new insights into the complex signaling network mediated by histamine and further knowledge for the rational use of its ligands.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23462507      PMCID: PMC3629830          DOI: 10.1124/mol.112.083394

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  43 in total

1.  Expression of a G protein-coupled receptor (GPCR) leads to attenuation of signaling by other GPCRs: experimental evidence for a spontaneous GPCR constitutive inactive form.

Authors:  Maria Rosario Tubio; Natalia Fernandez; Carlos Patricio Fitzsimons; Sabrina Copsel; Sergio Santiago; Carina Shayo; Carlos Davio; Federico Monczor
Journal:  J Biol Chem       Date:  2010-03-18       Impact factor: 5.157

2.  Multidrug resistance protein 4 (MRP4/ABCC4) regulates cAMP cellular levels and controls human leukemia cell proliferation and differentiation.

Authors:  Sabrina Copsel; Corina Garcia; Federico Diez; Monica Vermeulem; Alberto Baldi; Liliana G Bianciotti; Frans G M Russel; Carina Shayo; Carlos Davio
Journal:  J Biol Chem       Date:  2011-01-04       Impact factor: 5.157

3.  Ubiquitin/proteasome-dependent down-regulation following clathrin-mediated internalization of histamine H1-receptors in Chinese hamster ovary cells.

Authors:  Shigeru Hishinuma; Hiroshi Komazaki; Hiroyuki Fukui; Masaru Shoji
Journal:  J Neurochem       Date:  2010-03-04       Impact factor: 5.372

4.  Histamine and its receptors.

Authors:  Mike E Parsons; C Robin Ganellin
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

5.  Airway smooth muscle prostaglandin-EP1 receptors directly modulate beta2-adrenergic receptors within a unique heterodimeric complex.

Authors:  Dennis W McGraw; Kathryn A Mihlbachler; Mary Rose Schwarb; Fahema F Rahman; Kersten M Small; Khalid F Almoosa; Stephen B Liggett
Journal:  J Clin Invest       Date:  2006-05       Impact factor: 14.808

Review 6.  Histamine, histamine receptors and their role in immune pathology.

Authors:  M Jutel; M Akdis; C A Akdis
Journal:  Clin Exp Allergy       Date:  2009-12       Impact factor: 5.018

Review 7.  Physiological relevance of GPCR oligomerization and its impact on drug discovery.

Authors:  Rosemarie Panetta; Michael T Greenwood
Journal:  Drug Discov Today       Date:  2008-10-14       Impact factor: 7.851

8.  Histamine H2 receptor trafficking: role of arrestin, dynamin, and clathrin in histamine H2 receptor internalization.

Authors:  Natalia Fernandez; Federico Monczor; Alberto Baldi; Carlos Davio; Carina Shayo
Journal:  Mol Pharmacol       Date:  2008-07-10       Impact factor: 4.436

Review 9.  Arrestin development: emerging roles for beta-arrestins in developmental signaling pathways.

Authors:  Jeffrey J Kovacs; Makoto R Hara; Chandra L Davenport; Jihee Kim; Robert J Lefkowitz
Journal:  Dev Cell       Date:  2009-10       Impact factor: 12.270

10.  Histamine acting on H1 receptor promotes inhibition of proliferation via PLC, RAC, and JNK-dependent pathways.

Authors:  Cintia Notcovich; Federico Diez; Maria Rosario Tubio; Alberto Baldi; Marcelo G Kazanietz; Carlos Davio; Carina Shayo
Journal:  Exp Cell Res       Date:  2009-11-11       Impact factor: 3.905

View more
  11 in total

1.  Desensitization of human CRF2(a) receptor signaling governed by agonist potency and βarrestin2 recruitment.

Authors:  Richard L Hauger; J Alberto Olivares-Reyes; Sandra Braun; Judith Hernandez-Aranda; Christine C Hudson; Eric Gutknecht; Frank M Dautzenberg; Robert H Oakley
Journal:  Regul Pept       Date:  2013-06-29

2.  Histamine facilitates GABAergic transmission in the rat entorhinal cortex: Roles of H1 and H2 receptors, Na+ -permeable cation channels, and inward rectifier K+ channels.

Authors:  Nicholas I Cilz; Saobo Lei
Journal:  Hippocampus       Date:  2017-02-28       Impact factor: 3.899

3.  Can H2 -receptor upregulation and raised histamine explain an anaphylactoid reaction on cessation of ranitidine in a 19-year-old female? A case report.

Authors:  Susan J Allen; Paul L Chazot; C Jane Dixon
Journal:  Br J Clin Pharmacol       Date:  2018-04-18       Impact factor: 4.335

Review 4.  The Roles of Cardiovascular H2-Histamine Receptors Under Normal and Pathophysiological Conditions.

Authors:  Joachim Neumann; Uwe Kirchhefer; Stefan Dhein; Britt Hofmann; Ulrich Gergs
Journal:  Front Pharmacol       Date:  2021-12-20       Impact factor: 5.810

5.  Basal Serum Diamine Oxidase Levels as a Biomarker of Histamine Intolerance: A Retrospective Cohort Study.

Authors:  Valentina Cucca; Giuseppe A Ramirez; Patrizia Pignatti; Chiara Asperti; Marco Russo; Emanuel Della-Torre; Daniela Breda; Samuele E Burastero; Lorenzo Dagna; Mona-Rita Yacoub
Journal:  Nutrients       Date:  2022-04-05       Impact factor: 5.717

6.  Altered esophageal histamine receptor expression in Eosinophilic Esophagitis (EoE): implications on disease pathogenesis.

Authors:  Jamie Merves; Prasanna Modayur Chandramouleeswaran; Alain J Benitez; Amanda B Muir; Anna J Lee; Diana M Lim; Kara Dods; Isha Mehta; Eduardo D Ruchelli; Hiroshi Nakagawa; Jonathan M Spergel; Mei-Lun Wang
Journal:  PLoS One       Date:  2015-02-27       Impact factor: 3.240

7.  Histaminergic system in brain disorders: lessons from the translational approach and future perspectives.

Authors:  Diego Baronio; Taylor Gonchoroski; Kamila Castro; Geancarlo Zanatta; Carmem Gottfried; Rudimar Riesgo
Journal:  Ann Gen Psychiatry       Date:  2014-11-18       Impact factor: 3.455

Review 8.  Histamine, histamine receptors, and neuropathic pain relief.

Authors:  Ilona Obara; Vsevolod Telezhkin; Ibrahim Alrashdi; Paul L Chazot
Journal:  Br J Pharmacol       Date:  2019-06-07       Impact factor: 8.739

9.  Histamine H1 receptor on astrocytes and neurons controls distinct aspects of mouse behaviour.

Authors:  Anikó Kárpáti; Takeo Yoshikawa; Fumito Naganuma; Takuro Matsuzawa; Haruna Kitano; Yo Yamada; Mariko Yokoyama; Akira Futatsugi; Katsuhiko Mikoshiba; Kazuhiko Yanai
Journal:  Sci Rep       Date:  2019-11-11       Impact factor: 4.379

Review 10.  Histamine in cancer immunology and immunotherapy. Current status and new perspectives.

Authors:  María de la Paz Sarasola; Mónica A Táquez Delgado; Melisa B Nicoud; Vanina A Medina
Journal:  Pharmacol Res Perspect       Date:  2021-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.